EGElizabeth E. Gerard

Elizabeth E. Gerard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elizabeth E. Gerard has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Initiation and Duration of Breastfeeding in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study

    by Elizabeth E. Gerard, Kimford J. Meador, Chelsea P. Robalino, Carrie Anne Brown, Abigail G. Matthews, P. Emanuela Voinescu, Laura A. Kalayjian, Evan Gedzelman, Julie Hanna, Jennifer Cavitt, et al.

    Background and Objectives: Breastfeeding has important health benefits for both mother and child. We characterize breastfeeding initiation and duration in mothers with epilepsy relative to control mothers in a large prospective cohort. Methods: The Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) study is a prospective, multi-center observational, US cohort study. Pregnant subjects with and without epilepsy, aged 14-45, were enrolled 12/19/12 to 2/11/16. Exclusion criteria included IQ 20 weeks at enrollment. Breastfeeding assessed via electronic diary and at study visits until 2 years postpartum. Odds of initiating breastfeeding was compared between groups using unadjusted and adjusted logistic regression models. Duration of breastfeeding was compared between groups using the log-rank test. Results: 351 pregnant subjects with epilepsy and 105 pregnant controls enrolled. Breastfeeding data available for 325 mothers with epilepsy and 98 controls. Study groups were similar demographically except race (P=0.008); 84.9% of mothers with epilepsy and 71.4% of controls were white. Mean IQ was lower in mothers with epilepsy compared with controls (97.7 vs. 104.2, PP=0.004)], but not in adjusted model [OR 0.5 (95% CI 0.2,1.0), P=0.051)]. Factors associated with breastfeeding were higher maternal education and IQ. There was no difference in duration of breastfeeding between mothers with and without epilepsy [median duration 8.5 months vs. 9.9 months, P=0.793)]. Among mothers with epilepsy, both convulsive seizures and all seizures that impair awareness during pregnancy were associated with lower breastfeeding initiation [OR 0.4 (95% CI 0.2,0.8), P=0.013) and OR 0.4 (95% CI 0.2,0.8), (P=0.003) respectively]. Any peripartum seizures were associated with shorter breastfeeding duration [median 6 months vs. 9.7 months, (P=0.040)]. Discussion: Mothers with epilepsy were less likely to initiate breastfeeding compared to controls, however this difference was not significant when controlling for maternal IQ and education level. Continuation of breastfeeding once initiated was not different between mothers with and without epilepsy. Seizure control was associated with breastfeeding initiation and duration in mothers with epilepsy.


  • Contraception, fecundity, and pregnancy in women with epilepsy: an update on recent literature

    by Alexa King, Elizabeth E. Gerard

    Purpose of review: Caring for women with epilepsy requires specialized knowledge about potential teratogenicity of antiseizure medications, interactions with hormonal contraception, and pregnancy outcomes. Recent findings: There has been an improvement in understanding the cognitive outcomes of infants exposed in utero in recent years. Folic acid supplementation helps mitigate the cognitive teratogenicity of antiseizure medications. Recent updates provide reassurance that seizure frequency tends to remain stable throughout pregnancy. There is conflicting evidence about the fecundity impact of epilepsy and antiseizure medications in women with epilepsy. Summary: Recent research highlights the importance of early counseling about the risks and interactions of contraception, pregnancy, and antiseizure medications. More research is needed to understand fertility in women with epilepsy.


  • Contraceptive vaginal ring reduces lamotrigine levels

    by Alexa King, Elizabeth Bachman, Micheal P. Macken, Jungwha Lee, Elizabeth E. Gerard


  • Clinical classification of post anoxic myoclonic status

    by Yara Mikhaeil-Demo, Jay R. Gavvala, Irena I. Bellinski, Micheal P. Macken, Aditi Narechania, Jessica W. Templer, Stephen VanHaerents, Stephan U. Schuele, Elizabeth E. Gerard


  • Open Access

    Counseling by epileptologists affects contraceptive choices of women with epilepsy

    by Alyssa R. Espinera, Jay Gavvala, Irena Bellinski, Jeffrey Kennedy, Micheal P. Macken, Aditi Narechania, Jessica Templer, Stephen VanHaerents, Stephan U. Schuele, Elizabeth E. Gerard


  • Managing Epilepsy in Women

    by Elizabeth E. Gerard, Kimford J. Meador

    Es of cognitive development continue to confirm that valproate poses a significantly increased risk of structural and cognitive teratogenesis. In contrast, data thus far suggest that lamotrigine and levetiracetam are associated with a relatively low risk for both anatomic and developmental adverse effects, although further studies are needed for these and other AEDs. The intrauterine device is a good contraceptive option for many women with epilepsy as it is highly effective and not subject to the drug-drug interactions seen between hormonal contraception and many AEDs. Hormonal-sensitive seizures are common among women with epilepsy; however, highly effective treatments for refractory catamenial seizures are limited. Summary: Women with epilepsy should be counseled early and regularly about reproductive health as it relates to epilepsy. AED selection for women of childbearing age should take future pregnancies and contraceptive needs into consideration....


  • Open Access

    An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes

    by Kimford J. Meador, Elizabeth E. Gerard

    Antiepileptic drugs (AEDs) are prescribed commonly to women of childbearing age. In utero exposure to some AEDs can have significant cognitive and behavioral consequences for the unborn child. Recently, prospective studies of women taking AEDs during pregnancy have added significantly to our understanding of cognitive and behavioral teratogenic risks posed by fetal AED exposure. Valproate is clearly associated with impaired cognitive development as well as an increased risk of disorders such as autism and autism spectrum disorder. Exposure to carbamazepine, lamotrigine, levetiracetam, or phenytoin monotherapy is associated with more favorable cognitive and behavioral outcomes than valproate, but more data are required to clarify if these AEDs have more subtle effects on cognition and behavior. There are insufficient data on the developmental effects of other AEDs in humans. Further, the underlying mechanisms of cognitive teratogenesis are poorly understood, including the genetic factors that affect susceptibility to AEDs.


  • Continuous EEG monitoring: A survey of neurophysiologists and neurointensivists

    by Jay Gavvala, Nicholas Abend, Suzette LaRoche, Cecil Hahn, Susan T. Herman, Jan Claassen, Mícheál Macken, Stephan Schuele, Elizabeth Gerard, the Critical Care EEG Monitoring Research Consortium (CCEMRC)

    Summary: Objective: Continuous EEG monitoring (cEEG) of critically ill adults is being used with increasing frequency, and practice guidelines on indications for cEEG monitoring have recently been published. However, data describing the current practice of cEEG in critically ill adults is limited. We aimed to describe the current practice of cEEG monitoring in adults in the United States.Methods: A survey assessing cEEG indications and procedures was sent to one intensivist and one neurophysiologist responsible for intensive care unit (ICU) cEEG at 151 institutions in the United States. At some institutions only one physician could be identified.Results: One hundred thirty‐seven physicians from 97 institutions completed the survey. Continuous EEG is utilized by nearly all respondents to detect nonconvulsive seizures (NCS) in patients with altered mental status following clinical seizures, intra cerebral hemorrhage (ICH), traumatic brain injury, and cardiac arrest, as well as to characterize abnormal movements suspected to be seizures. The majority of physicians monitor comatose patients for 24–48 h. In an ideal situation with unlimited resources, 18% of respondents would increase cEEG duration. Eighty‐six percent of institutions have an on‐call EEG technologist available 24/7 for new patient hookups, but only 26% have technologists available 24/7 in‐house. There is substantial variability in who reviews EEG and how frequently it is reviewed as well as use of quantitative EEG.Significance: Although there is general agreement regarding the indications for ICU cEEG, there is substantial interinstitutional variability in how the procedure is performed.


  • “Ictal” lateralized periodic discharges

    by Indranil Sen-Gupta, Stephan U. Schuele, Micheal P. Macken, Mary J. Kwasny, Elizabeth E. Gerard